Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - SHARES OUTSTANDING
Shares Outstanding CRVS - Corvus Pharmaceuticals, Inc.
48 M
LAST VALUE
7.12%
2 YEAR CAGR
11.79%
5 YEAR CAGR
0.00%
10 YEAR CAGR